Prudential Financial
IBRX icon

Prudential Financial’s ImmunityBio IBRX Stock Holding History

Prudential Financial’s Portfolio IBRX Stock Details IBRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$908K Sell
103,670
-164,700
-61% -$1.25M ﹤0.01% 1686
2026
Q1 		$2.06M Buy
268,370
+252,230
+1,563% +$1.73M ﹤0.01% 1299
2025
Q4 		$32K Sell
16,140
-8,600
-35% -$19.5K ﹤0.01% 2174
2025
Q3 		$60.9K Hold
24,740
– – ﹤0.01% 2320
2025
Q2 		$65.3K Buy
+24,740
New +$66.5K ﹤0.01% 2320
2022
Q1 		– Sell
-75,365
Closed -$459K – 2647
2021
Q4 		$459K Sell
75,365
-29,255
-28% -$220K ﹤0.01% 2232
2021
Q3 		$1.02M Buy
+104,620
New +$1.15M ﹤0.01% 1795

Other funds holding IBRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Prudential Financial's IBRX Position: Q2 2026 in Review

Prudential Financial reduced its ImmunityBio (IBRX) stake by 61% in Q2 2026, selling an estimated $1.25M and leaving 103,670 shares worth $908K. The position accounts for ﹤0.01% of the portfolio, ranked #1686.

Prudential Financial first reported a position in IBRX in Q3 2021 and has held it in 7 quarters since. The position peaked at $2.06M in Q1 2026. 405 funds tracked by Wall St. Rank hold IBRX as of Q2 2026.

  • Prudential Financial held 103,670 shares of ImmunityBio worth $908K as of Q2 2026.
  • Prudential Financial sold 164,700 ImmunityBio shares in Q2 2026, an estimated $1.25M.
  • ImmunityBio made up ﹤0.01% of Prudential Financial's portfolio in Q2 2026, its #1686 holding.
  • Prudential Financial first reported a position in ImmunityBio in Q3 2021 and has held it in 7 quarters since.
  • Prudential Financial's ImmunityBio position peaked at $2.06M in Q1 2026.
  • 405 funds tracked by Wall St. Rank held ImmunityBio as of Q2 2026.

Based on Prudential Financial's 13F filing for Q2 2026, filed 12 Aug 2026.